scholarly journals Keratin 13 point mutation underlies the hereditary mucosal epithelia disorder white sponge nevus

1995 ◽  
Vol 11 (4) ◽  
pp. 453-455 ◽  
Author(s):  
Gabriela Richard ◽  
Vincenzo De Laurenzi ◽  
Biagio Didona ◽  
Sherri J. Bale ◽  
John G. Compton
2001 ◽  
Vol 80 (3) ◽  
pp. 919-923 ◽  
Author(s):  
A. Terrinoni ◽  
E.L. Rugg ◽  
E.B. Lane ◽  
G. Melino ◽  
D.H. Felix ◽  
...  

Author(s):  
Yasuyuki Shibuya ◽  
Jianming Zhang ◽  
Satoshi Yokoo ◽  
Masahiro Umeda ◽  
Takahide Komori

2017 ◽  
Vol 5 (9) ◽  
pp. 1503-1509 ◽  
Author(s):  
Stephanie B. de Haseth ◽  
Egbert Bakker ◽  
Maarten H. Vermeer ◽  
Hakima el Idrissi ◽  
Tjalling Bosse ◽  
...  

2017 ◽  
Vol 47 (2) ◽  
pp. 152-157 ◽  
Author(s):  
Maria Westin ◽  
Elham Rekabdar ◽  
Lena Blomstrand ◽  
Per Klintberg ◽  
Mats Jontell ◽  
...  

Meta Gene ◽  
2014 ◽  
Vol 2 ◽  
pp. 374-383 ◽  
Author(s):  
Wenping Cai ◽  
Zhenghu Chen ◽  
Beizhan Jiang ◽  
Fang Yu ◽  
Ping Xu ◽  
...  

Author(s):  
Wenping Cai ◽  
Beizhan Jiang ◽  
Fang Yu ◽  
Jianhua Yang ◽  
Zhenghu Chen ◽  
...  

White sponge nevus (WSN) in the oral mucosa is a rare autosomal dominant genetic disease. The involved mucosa is white or greyish, thickened, folded and spongy. The genes associated with WSN include mutant cytokeratin keratin 4 (KRT4) and keratin 13 (KRT13). In recent years, new cases of WSN and associated mutations have been reported. Here, we summarise the recent progress in our understanding of WSN, including clinical reports, genetics, animal models, treatment, pathogenic mechanisms and future directions. Gene-based diagnosis and gene therapy for WSN may become available in the near future and could provide a reference and instruction for treating other KRT-associated diseases.


2020 ◽  
Vol 468 (1-2) ◽  
pp. 146-153
Author(s):  
Laura Simonson ◽  
Samantha Vold ◽  
Colton Mowers ◽  
Randall J. Massey ◽  
Irene M. Ong ◽  
...  

1993 ◽  
Vol 69 (03) ◽  
pp. 217-220 ◽  
Author(s):  
Jonathan B Rosenberg ◽  
Peter J Newman ◽  
Michael W Mosesson ◽  
Marie-Claude Guillin ◽  
David L Amrani

SummaryParis I dysfibrinogenemia results in the production of a fibrinogen molecule containing a functionally abnormal γ-chain. We determined the basis of the molecular defect using polymerase chain reaction (PCR) to amplify the γ-chain region of the Paris I subject’s genomic DNA. Comparative sequence analysis of cloned PCR segments of normal and Paris I genomic DNA revealed only an A→G point mutation occurring at nucleotide position 6588 within intron 8 of the Paris I γ-chain gene. We examined six normal individuals and found only normal sequence in this region, indicating that this change is not likely to represent a normal polymorphism. This nucleotide change leads to a 45 bp fragment being inserted between exons 8 and 9 in the mature γparis I chain mRNA, and encodes a 15 amino acid insert after γ350 [M-C-G-E-A-L-P-M-L-K-D-P-C-Y]. Alternative splicing of this region from intron 8 into the mature Paris I γ-chain mRNA also results after translation into a substitution of S for G at position γ351. Biochemical studies of 14C-iodoacetamide incorporation into disulfide-reduced Paris I and normal fibrinogen corroborated the molecular biologic predictions that two additional cysteine residues exist within the γpariS I chain. We conclude that the insertion of this amino acid sequence leads to a conformationallyaltered, and dysfunctional γ-chain in Paris I fibrinogen.


2015 ◽  
Author(s):  
Emma Webb ◽  
Meena Balasubramanian ◽  
Trevor Cole ◽  
Sue Stewart ◽  
Nicola Crabtree ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document